Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdVise: Brincidofovir in Adenovirus Infection
NCT02087306Phase 3Completed
- Sponsor
- Chimerix Inc.
- Start
- Mar 2014
- Primary completion
- Jun 2016
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of brincidofovir in adenovirus infection, sponsored by Chimerix Inc.. Started Mar 2014; status: completed.
02
Drugs
brincidofovir
03
Conditions
adenovirus infection
Beyond the preview
Go deeper on NCT02087306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02087306.